Principal Investigator
Michael Ivan
Enrollment Status
Closed
Clinical Trial ID
Institutional Protocol #
20210749
Clinical Trial Summary
A Phase 3 Multicenter Study of Gleolan (Aminolevulinic Acid Hydrochloride) to Enhance Visualization of Tumor in Patients with Newly Diagnosed or Recurrent Meningiomas
Phase
Phase III
Funding Agency/Sponsor
Industrial
Disease
Neurological Cancer
Contact Information
Phone Number
+1 (305) 2433344